Could a bone marrow drug slow Alzheimer's?
NCT ID NCT04902703
Summary
Researchers are testing if a drug called sargramostim, already approved for other uses, is safe and might help people with mild-to-moderate Alzheimer's disease. The 6-month study with 42 participants will check if the drug can slow or stop cognitive decline and improve daily function. This builds on earlier research that showed the drug was safe for short-term use in Alzheimer's patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Colorado Anschutz Medical Campus
RECRUITINGAurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.